Standard units for cannabis dose: Why is it important to standardize cannabis dose for drug policy and how can we enhance its place on the public health agenda?
Int J Drug Policy. 2021 Nov:97:103350.
doi: 10.1016/j.drugpo.2021.103350.
Epub 2021 Jul 7.
1 Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain. Electronic address: hlopez@clinic.cat.
2 Grup Recerca Addiccions Clínic (GRAC-GRE). Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Barcelona 08036, Spain.
3 Department of Psychiatry, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands.
4 University Institute of Maia - ISMAI and Interdisciplinary Research Centre for Human Rights - JusGov, University of Minho- Avenida Carlos de Oliveira Campos, 4475-690 Maia, Portugal and JusGov - Escola de Direito, Campus de Gualtar, Braga 4710-057, Portugal.
5 King's College London, Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, London SE5 8BB, United Kingdom.
6 Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Belgium. European Federation of Addiction Societies (EUFAS), Belgium.
8 Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, United Kingdom.
9 Clinical Psychopharmacology Unit, Research Department of Clinical and Health Psychology, University College London, London WC1E 7HB, United Kingdom; NIHR University College London Hospitals Biomedical Research Centre, University College Hospital, London, United Kingdom.
10 Departament of Sociology, Purdue University, United States.
11 Bonger Institute of Criminology, University of Amsterdam, the Netherlands.
12 School of Behavioural & Health Sciences Faculty of Health Sciences, Australia.
13 Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Chemnitzer Str. 46, Dresden 01187, Germany; Center for Interdisciplinary Addiction Research of Hamburg University (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, Hamburg 20246, Germany; Department of Psychiatry, Medical Faculty, University of Leipzig, Semmelweisstraße 10, Leipzig 04103, Germany.
14 European Monitoring Centre for Drugs and Drug Addiction, Portugal.
15 Institute for Mental Health Policy Research & Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Canada; Dalla Lana School of Public Health and Department of Psychiatry, University of Toronto (UofT), Canada; Epidemiological Research Unit, Technische Universität Dresden, Klinische Psychologie & Psychotherapie, Dresden, Germany; Department of International Health Projects, Institute for Leadership and HealthManagement, I.M.Sechenov First Moscow State Medical University, Moscow, Russian Federation.
16 Center for Interdisciplinary Addiction Research (ZIS) of Hamburg University, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, Hamburg 20246, Germany.
17 Public Health Institute, Liverpool John Moores University, Exchange Station Tithebarn Street, Liverpool L2 2QP, United Kingdom.
18 Student Governance and Leadership in European Public Health, Maastricht University, the Netherlands.
19 Department of Sociology, The Ohio State University, Columbus, OH, United States.
20 Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland; University of Michigan, Ann Arbor, MI, United States.